RRC ID 68483
著者 Enosawa S, Miyashita T, Suzuki S, Li XK, Tsunoda M, Amemiya H, Yamanaka M, Hiramatsu S, Tanimura N, Omasa T, Suga K, Matsumura T.
タイトル Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liver.
ジャーナル Cell Transplant
Abstract Glutamine synthetase (GS) is involved in an accessory pathway of ammonia removal in mammals. To develop a bioartificial liver with a human cell line, GS gene was transfected into HepG2 cells, which had no ammonia removal activity. After culturing in the presence of methionine sulfoximine (MSX), a GS inhibitor, we obtained a MSX-resistant HepG2 subline (GS-HepG2), which had amplified GS gene; ammonia removal activity was estimated to be 1/7 of that of rat primary culture hepatocytes. The cells were cultured in a circulatory flow bioreactor for 109 days, while they multiplied from 5 x 10(7) to 4 x 10(9) cells. Three days after inoculation, the ammonia level of the culture medium was lowered to a level maintained thereafter, suggesting that using recombinant cell lines for bioartificial livers enables long-term repeated treatment for hepatic failure patient. Judging from the rate of decrease in the amount of the added ammonia, the ammonia removal capability of 4 x 10(9) GS-HepG2 cells was almost equivalent to 5 x 10(8) porcine hepatocytes inoculated into the circulatory flow bioreactor. Apart from their ammonia removal activity, GS-HepG2 cells eliminated human tumor necrosis factor-alpha (TNF-alpha). Cytokine removal therefore promises to be another useful property of bioreactor cells.
巻・号 9(5)
ページ 711-5
公開日 2000-1-1
DOI 10.1177/096368970000900520
PMID 11144971
MeSH Air Movements Ammonia / metabolism Bioreactors* Cell Culture Techniques / methods* Cell Line Glucose / metabolism Glutamate-Ammonia Ligase / genetics* Glutamate-Ammonia Ligase / metabolism Humans Liver, Artificial* Recombinant Proteins / metabolism Transfection* Tumor Necrosis Factor-alpha / metabolism
IF 3.341
リソース情報
ヒト・動物細胞 Hep G2(RCB0459)